Octave Specialty Group, Inc.
NYSE:OSGInsurance - Specialty
-$0.07 today
- Market cap
- $221.70M
- Beta
- 0.85
- P/E (TTM)
- -1.3
- EPS (TTM)
- -$4.40
Volume 0.29M
Average 0.67M
OSG Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
Octave Specialty Group, Inc.NYSE: OSG
Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026
Net change in cash grows, but more slowly than its trailing trend
Q1 FY2026 net change in cash of $25.1M rose 88.8% year over year, behind the +118.7% change in trailing-twelve-month net change in cash. Sequentially, it rose 50.5% from the prior quarter. Over 3 fiscal years it compounded at +31.8% a year.
Context
- Net change in cash amounted to 9.1% of revenue in FY2025, down 2.8 pp from a year earlier.
- Net change in cash increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +88.8% toward the trailing-twelve-month pace of +118.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- 22.82M USD
- Year-over-year change
- -18.7%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 22.82M | -18.7% |
| FY2024 | 2024-12-31 | 28.05M | -86.8% |
| FY2023 | 2023-12-31 | 213M | +2036.2% |
| FY2022 | 2022-12-31 | 9.97M | +183.1% |
| FY2021 | 2021-12-31 | (12M) | — |
Net Change in Cash vs competitors
How OSG compares with its peers on the latest reported figures
- Peers report in different currencies, so net change in cash is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +118.7% is the highest of 11, against a peer median of -114.5%.
- Net change in cash amounts to 14.3% of revenue for OSG, versus a peer median of 10.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | CA$227.98M CAD | +61.3% | — | 70.1% | |
TWFGTWFG, Inc. Common Stock | LTM Mar 2026 | $64.63M USD | -136.5% | +110.5% | 25.3% |
| LTM Mar 2026 | $46.32M USD | -209.5% | — | 10.3% | |
| LTM Mar 2026 | $41.88M USD | +118.7% | +31.8% | 14.3% | |
| LTM Mar 2026 | $30.09M USD | -49.1% | — | 12.1% | |
| LTM Mar 2026 | $26.03M USD | -158.6% | +4.1% | 18.1% | |
| LTM Mar 2026 | $23.25M USD | -672.4% | +29.4% | 3.5% | |
| LTM Mar 2026 | $18.07M USD | -120.7% | -78.0% | 9.2% | |
| LTM Mar 2026 | $16.03M USD | -84.0% | -55.1% | 11.2% | |
| LTM Mar 2026 | $9M USD | +112.0% | -42.0% | 10.0% | |
| LTM Mar 2026 | $3.34M USD | -108.3% | — | 1.7% | |
| Peer median (excluding OSG) | — | -114.5% | -19.0% | 10.7% | |
Competitors are the stored peer set for OSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (16M) | (35.24M) | 4M | (58.92M) | (95.8M) |
| Depreciation & Amortization | 57M | 3.79M | 31M | 19.95M | 41.95M |
| Deferred Income Tax | 2M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 14M | 11.23M | 17M | 9.36M | 9.71M |
| Change in Working Capital | (95M) | 26.17M | 130M | 15.02M | (3.58M) |
| Accounts Receivables | 48M | (13.48M) | (21M) | (11.33M) | (49.58M) |
| Inventory | (6M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 6M | 6M | 52M | 0 | 30.74M |
| Other Working Capital | (143M) | 33.65M | 99M | 26.35M | 15.25M |
| Other Non-Cash Items | (93M) | 64.42M | 18M | 15.36M | (4.56M) |
| Operating Cash Flow | (131M) | 70.37M | 200M | 762K | (52.28M) |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 0 | (18.44M) | (7M) | (229.66M) | 189.36M |
| Purchases of Investments | (470M) | (96.66M) | (495M) | (62.99M) | (44.4M) |
| Sales of Investments | 1.07B | 71.61M | 541M | 130.03M | 65.02M |
| Other Investing Activities | 175M | 2.33M | 396M | (3.75M) | (10.05M) |
| Investing Cash Flow | 776M | (41.16M) | 435M | (166.37M) | 199.94M |
| Debt Repayment | (467M) | (1.54B) | (97M) | 147M | (32.53M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 17M |
| Common Stock Repurchased | (6M) | (14.22M) | (5M) | (11.7M) | (29.94M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (184M) | 1.55B | (321M) | 58.92M | (80.83M) |
| Financing Cash Flow | (657M) | (19.24M) | (423M) | 194.22M | (126.3M) |
| Effect of Forex Changes | (1M) | 1M | 1M | (558K) | 1.46M |
| Net Change in Cash | (12M) | 9.97M | 213M | 28.05M | 22.82M |
| Free Cash Flow | (131M) | 70.37M | 200M | 762K | (52.28M) |
Octave Specialty Group, Inc.
NYSE:OSG
Intrinsic Alpha fair value
Locked
Current Price
$4.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.